@HypoResolve on Feb 01, 2023
Article on Hypo-RESOLVE featured in IHI's Newsroom
The Hypo-RESOLVE Consortium is proud to announce that on 24th January 2023 an article featuring Hypo-RESOLE was published in the IHI's online Newsroom. The article 'People with diabetes often can’t “f...
Fourth Hypo-RESOLVE progress report
The Hypo-RESOLVE consortium is happy to announce that the EC accepted its 4th progress report covering the achievements of the third year in Hypo-RESOLVE. The Hypo-RESOLVE consortium is proud to repor...
The Hypo-RESOLVE consortium sends season's greetings
The Hypo-RESOLVE consortium sends season’s greetings and best wishes for the new year to everybody contributing to the project or supporting Hypo-RESOLVE by following us either here or on Twitter. Tha...
Hypo-RESOLVE Annual Meeting 2022 – first in-person meeting since start of COVID pandemic
After over two years of online meetings, the Hypo-RESOLVE consortium was finally able to meet in person again. Partner Abbott kindly hosted the consortium on their premises in Wiesbaden/ Delkenheim fr...
Hypo-RESOLVE consortium @EASD
Various Hypo-RESOLVE members will be featuring at the EASD conference taking place in Stockholm from 19-23 September 2022. Take a look at their contributions in this special Hypo-RESOLVE EASD program...
Paper on Hypo-METRICS study protocol published
The Hypo-RESOLVE consortium is proud to announce that a paper has been published on the Hypo-METRICS study protocol in Diabetic Medicine, namely